Vir Biotechnology Inc’s filing revealed that its Director Napolitano Janet unloaded Company’s shares for reported $16149.0 on Jun 02 ’25. In the deal valued at $5.05 per share,3,200 shares were sold. As a result of this transaction, Napolitano Janet now holds 16,416 shares worth roughly $85855.68000000001.
Then, JANET ANN NAPOLITANO bought 3,200 shares, generating $15,808 in total proceeds.
Before that, De Backer Marianne sold 79,712 shares. Vir Biotechnology Inc shares valued at $474,239 were divested by the Chief Executive Officer at a price of $5.95 per share. As a result of the transaction, De Backer Marianne now holds 769,505 shares, worth roughly $4.02 million.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock jump 3.16% to $5.23. Over the last five days, the stock has gained 12.23%. Vir Biotechnology Inc shares have fallen nearly -28.75% since the year began. Nevertheless, the stocks have fallen -49.66% over the past one year. While a 52-week high of $14.45 was reached on 01/08/25, a 52-week low of $4.32 was recorded on 05/15/25. SMA at 50 days reached $5.58, while 200 days put it at $7.67.
Levels Of Support And Resistance For VIR Stock
The 24-hour chart illustrates a support level at 5.03, which if violated will result in even more drops to 4.84. On the upside, there is a resistance level at 5.36. A further resistance level may holdings at 5.49. The Relative Strength Index (RSI) on the 14-day chart is 51.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 6.67%. Stochastics %K at 71.01% indicates the stock is a holding.
How much short interest is there in Vir Biotechnology Inc?
A steep rise in short interest was recorded in Vir Biotechnology Inc stocks on 2025-05-15, growing by 0.78 million shares to a total of 10.94 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 10.17 million shares. There was a rise of 7.09%, which implies that there is a positive sentiment for the stock.
